Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.64 USD | -1.77% | -4.56% | +71.85% |
May. 08 | Transcript : Y-mAbs Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 07 | Earnings Flash (YMAB) Y-MABS THERAPEUTICS Posts Q1 Revenue $19.9M, vs. Street Est of $22.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.85% | 520M | |
+9.47% | 114B | |
+11.57% | 104B | |
-13.79% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.61% | 17.89B | |
+7.48% | 14.28B | |
+35.98% | 12.55B |
- Stock Market
- Equities
- YMAB Stock
- News Y-mAbs Therapeutics, Inc.
- Y-mAbs Therapeutics Chief Financial Officer Bo Kruse to Resign